November 12–16, 2026
Phoenix Convention Center – Phoenix, Arizona
Immunologic Changes in VITESSE: A 12-Month Study of Epicutaneous Immunotherapy in Children With Peanut Allergy
View Poster
Practicality of Daily Epicutaneous Immunotherapy in Young Children With Peanut Allergy
View Poster
Changes in Reaction Severity Following Epicutaneous Immunotherapy in Children With Peanut Allergy in the Phase 3 VITESSE Trial
View Poster